{"version":"1.0","type":"link","title":"Guided by target selection, inotuzumab ozogamicin successfully salvaged a patient with refractory follicular lymphoma after anti-CD19 and anti-CD22 CAR T-cell therapy: a case report and literature review.","author_name":"Li X 외","author_url":"https://prs-insight.online/author/Li%20X","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/161900","thumbnail_width":1200,"thumbnail_height":630}